Metabolic

TB-500

TB-500 is a synthetic research peptide commonly described as a fragment derived from thymosin beta-4. It is studied in preclinical models involving actin-associated cellular processes, cell migration, vascular responses and tissue-remodelling signalling. Evidence specific to TB-500 remains predominantly laboratory-based, and it has no approved therapeutic use. For qualified analytical and in-vitro research only — not for human or veterinary use, consumption or injection.